Pharma-Bio Serv Profit Margin 2012-2026 | PBSV

Current and historical gross margin, operating margin and net profit margin for Pharma-Bio Serv (PBSV) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Pharma-Bio Serv net profit margin as of July 31, 2026 is 2.66%.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Sector Industry Market Cap Revenue
Business Services Consulting Services $0.009B $0.009B
Pharma-Bio Serv, Inc. provides consulting solutions to the pharmaceutical, chemical, medical device and biotechnology industries. Its services include regulatory compliance, validation, technology transfer, engineering, project management, process support, web pages, portals development, digital art design, intranets, extranets, software development, microbiological testing services, chemical testing services and technical trainings/seminars. The company operates in the U.S, Ireland and Spain. Pharma-Bio Serv, Inc. is headquartered in Dorado, Puerto Rico.
Stock Name Country Market Cap PE Ratio
Equifax (EFX) United States $19.244B 19.88
Bureau Veritas Registre De Classification (BVRDF) France $14.189B 0.00
Gartner (IT) United States $12.097B 13.31
Booz Allen Hamilton Holding (BAH) United States $9.432B 11.45
Stantec (STN) Canada $7.914B 17.01
FTI Consulting (FCN) United States $4.007B 17.19
Exponent (EXPO) United States $3.234B 30.50
CBIZ (CBZ) United States $2.963B 14.68
Huron Consulting Group (HURN) United States $2.451B 18.21
Charles River Associates (CRAI) United States $1.032B 19.88
Hackett (HCKT) United States $0.273B 10.88
Information Services (III) United States $0.255B 20.27
Franklin Covey (FC) United States $0.201B 24.74
Accos (ACCL) Hong Kong, SAR China $0.040B 0.00
ATIF Holdings (ZBAI) China $0.011B 0.00
ATIF Holdings (AUC) China $0.009B 0.00